Skip to content

This week, with the holiday mood in the air, we award a turkey to the UK government for its mistakes preparing the November budget, spot doves and hawks flocking in the US Federal Reserve (Fed), notice savvy owls monitoring Europe’s bond market, and preview how chickens could emerge in distressed financial markets.

The economy

In the United Kingdom, the effects of the pre-budget uncertainty are very clear in the October GDP number, which showed the economy contracted by 0.1%. One-month numbers are notoriously volatile, but when it’s the service sector leading the contraction, one should take note. More discouraging is that the sector has posted negative month-on-month numbers for three of the last four months.1

Bond markets

The Fed dominated the news this past week, as the Federal Open Market Committee cut rates by 25 basis points. The most remarkable feature was the split vote with two members voting to hold rates steady, and one voting to cut them by a greater amount. This is neither hawkish nor dovish, but more a demonstration of independence. Also, the FOMC raised the projected rates in the “dot plot” (Summary of Economic Projections), with doves and hawks moving it in equal measure.

Bond markets liked what they saw in the United States. Not only did the Fed deliver the third rate cut in the cycle, the balanced nature of the internal debate suggests a degree of caution, which the bond market always welcomes!

What has been interesting to see in Europe is how the fears over German bond issuance are really gathering. Across Europe, spreads to German 10-year bunds are at one-year lows. There are a few exceptions, such as France, Sweden and Norway—countries that are also planning increased fiscal expenditure. Even the United Kingdom is at a one-year low! The flip side of this coin is the bond markets are expecting the Germans to spend and spend big. Conventional wisdom is that they will fail to spend the cash, as they did during the COVID-19 pandemic, and bond investors are savvy.

Equities

As the distractions of the holiday season begin to take effect, the stock market still managed to deliver the third consecutive week of gains. The message from our “worms” (charts plotted to show the movement in analysts’ estimates for the index over time, which tend to resemble squiggly lines) is this has been a very unusual year. First, earnings expectations set at the start of 2025 for Europe are being beaten, which is unusual; normally, analysts are too optimistic at the start of the year. Second, the forecasts for 2026 are rising sharply. Much of this has been due to better 2025 earnings in the last quarter, which, oddly, analysts have preferred to show in 2026 numbers, not 2025. This means to us there is real room for upside surprise in the fourth-quarter reporting season, which begins next year.

Parting shot

I was fortunate to be asked to participate in an exciting institutional investor workshop examining high-stress market scenarios/shocks and investor reactions to them. In every case, the portfolio that the audience preferred was the most defensive one, and it was also the portfolio that took the most action after the hypothetical event. In no case did the audience prefer to try to “sit it out” as was often the panel’s recommendation. It seems the world remains easily scared.



IMPORTANT LEGAL INFORMATION

This material is intended to be of general interest only and should not be construed as individual investment advice or a recommendation or solicitation to buy, sell or hold any security or to adopt any investment strategy. It does not constitute legal or tax advice.

The views expressed are those of the investment manager and the comments, opinions and analyses are rendered as at publication date and may change without notice. The information provided in this material is not intended as a complete analysis of every material fact regarding any country, region or market. All investments involve risks, including possible loss of principal.

Data from third party sources may have been used in the preparation of this material and Franklin Templeton ("FT") has not independently verified, validated or audited such data. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments opinions and analyses in the material is at the sole discretion of the user.

Products, services and information may not be available in all jurisdictions and are offered outside the U.S. by other FT affiliates and/or their distributors as local laws and regulation permits. Please consult your own financial professional or Franklin Templeton institutional contact for further information on availability of products and services in your jurisdiction.

Issued by Franklin Templeton Investment Management Limited (FTIML). Registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL. FTIML is authorised and regulated by the Financial Conduct Authority.

Investments entail risks, the value of investments can go down as well as up and investors should be aware they might not get back the full value invested.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.